(CIDRAP News) An advisory group of experts to the World Health Organization (WHO) welcomed findings from an independent review committee on the agency's 2009 H1N1 pandemic response and expressed concern about findings of narcolepsy in Europe possibly linked to a flu vaccine.
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.
(CIDRAP News) The World Health Organization's (WHO's) vaccine advisory group recently agreed to keep in place its guidance on pandemic H1N1 vaccines and discussed contamination issues related to the Rotarix rotovirus vaccine.
(CIDRAP News) Given signs that the pandemic H1N1 virus will continue its dominance over other flu strains, the World Health Organization (WHO) today recommended adding the pandemic strain as the H1N1 component of the seasonal flu vaccine for the Northern Hemisphere's next flu season.
(CIDRAP News) The World Health Organization (WHO) said today that the fast-tracking of vaccines for pandemic H1N1 influenza won't compromise safety, while acknowledging that clinical data will be limited when the first doses are administered.
(CIDRAP News) The World Health Organization (WHO) recommended today that governments put healthcare workers first in line for pandemic H1N1 vaccine when it becomes available and that countries should choose other priority groups on the basis of their own situations.
(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.
(CIDRAP News) The World Health Organization (WHO) says nations and vaccine manufacturers agreed yesterday that it may be feasible to set up a world stockpile of H5N1 influenza vaccine and find a way to ensure that developing countries could access pandemic flu vaccine supplies.